KPV

Target Inflammation with Precision

KPV (Lysine–Proline–Valine) is a synthetic tripeptide derived from alpha-melanocyte-stimulating hormone (α-MSH), studied for its potent anti-inflammatory and immunomodulatory properties. Unlike broader immune suppressants, KPV is investigated for its ability to regulate inflammatory signaling while preserving normal immune function.

Due to this targeted mechanism, KPV has become a compound of interest in research settings focused on inflammatory conditions, gut integrity, immune balance, and recovery-related healing processes.

Product features

• Synthetic tripeptide derived from alpha-MSH — designed for targeted inflammatory pathway research.
• Lyophilized (freeze-dried) formulation — supports stability and extended shelf life.
• Sterile 3 mL glass vial — packaged to maintain integrity during storage and handling.
• Butyl rubber stopper — engineered for reliable, multi-access sealing.
• ETO-sterilized & tamper-evident flip cap — ensures quality control and product security.

Key benefits (Research Highlights)

• Anti-inflammatory signaling modulation — studied for inhibiting pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6.
• NF-κB pathway inhibition — investigated for blocking a central driver of chronic inflammation in gastrointestinal and dermatological research models.
• Gut & intestinal barrier support — demonstrated protective effects on intestinal lining integrity in inflammatory bowel and permeability studies.
• Skin & wound healing research — associated with accelerated recovery in inflammatory skin conditions and reduced redness and irritation.
• Immune regulation without suppression — modulates macrophage and T-cell signaling while preserving systemic immune balance.
• Localized inflammatory control — research suggests beneficial effects with minimal systemic immune disruption.

Research reference: dosage ranges used in studies

Scientific literature evaluating KPV has explored varying quantities depending on study objectives related to inflammation control, gut health, dermatological recovery, and immune regulation.

These referenced quantities reflect controlled research protocols only and are provided strictly for informational and educational context. They are not intended to represent instructions, recommendations, or guidance for personal use.

Research reference: safety & tolerability observations

In controlled research environments, KPV has generally been described as well-tolerated. Research findings indicate that physiological responses may vary depending on inflammatory status, study duration, and tissue-specific focus.

• Localized inflammatory response modulation observed in multiple studies
• Minimal systemic immune effects reported in controlled models
• Overall favorable tolerability noted across gastrointestinal and dermatological research settings

These observations are derived from published research and are presented solely to support transparency within a research context. They should not be interpreted as medical advice or predictive outcomes.

Not sure if this compound aligns with your goals? Our consultation service is available to help you determine whether KPV fits your healing, immune, or recovery-focused research objectives.

Disclaimer: For research purposes only. Information provided is for educational reference and is not intended as medical advice.